Research Paper Volume 15, Issue 12 pp 5611—5649

Identifying the role of NUDCD1 in human tumors from clinical and molecular mechanisms: a study based on comprehensive bioinformatics and experimental validation


Figure 2. NUDCD1 expression levels in different types of human cancers. (A) NUDCD1 expression levels in different cancers and specific cancer subtypes from TIMER2. (B) NUDCD1 expression levels in DLBC, LAML and THYM (data from GEPIA2). (C) Expression status of the NUDCD1 gene in BRCA subtypes (data from TISIDB). (D) Expression levels of NUDCD1 total protein in breast cancer, ovarian cancer, colon cancer, clear cell RCC, UCEC and lung adenocarcinoma (data from UALCAN). (E) Enrichment scores for NUDCD1 in different cancers (data from GSCA). (F) Pathways affected by NUDCD1 mRNA expression (data from GSCA).